Wedescribe a case of pulmonary lymphangiomyomatosis (LAM)with chylothorax that developed in a 46-year-old Japanese woman.This patient exhibited clinical symptoms of dyspnea and chest X-ray showed right pleural effusion. Thoracocentesis demonstrated chylous effusion. Chest computed tomography (CT) scan revealed multiple cystic lesions. Subsequent thoracoscopy revealed the chylorrhea from swelled vessels on the diaphragm. The clinical diagnosis, based on histological examinations with biopsy specimens obtained by thoracoscopy, was pulmonary LAM.Although the hormonetherapy was not effective, chylous effusion was improved by the pleurodesis. Pulmonary LAM developing chylothorax is rare in Japan. (Internal Medicine 39: 738-741, 2000) 
Introduction
Pulmonary lymphangiomyomatosis (LAM) is a comparatively rare disease of womenof reproductive age characterized by hyperplasia of atypical smooth muscle of the lung, pleura, mediastinum, thoracic duct, and retroperitoneum (1).
The pulmonary manifestations are a combination of interstitial and destructive lung disease with proliferation of smooth muscle cells along lymphatics, small airways, and blood vessels and in the alveolar interstitium, interstitial fibrosis, arid focal destruction of the alveolar walls (1, 2). The clinical features include dyspnea, chylous effusion, hemoptysis and spontaneous pneumothorax (3). Although several cases of pulmonary LAM have been reported, a standardized treatment has yet to be established. Herein we report the rare case of a womandiagnosed with pulmonary LAMdeveloping chylothorax and treated with hormonal manipulation and pleurodesis.
For editorial comment, see p 683.
Case Report
The patient was a 46-year-old Japanese woman,144 cm tall and weighing 44.0 kg. She was admitted to our hospital complaining of a non-productive cough and progressive dyspnea of several days duration on April 8, 1998 . She had had a medical history of abdominal mass extraction thought to be LAM5 years earlier, however, the details were unclear. At that time, her chest roentgenogram was normal and she had not been diagnosed with pulmonary LAM.She was menstruant. She had not been diagnosed as having tuberous sclerosis. A family history of a neurocutaneus syndrome could not be elicited.
A physiological examination revealed percussion dullness over the lower right chest. The patient's body temperature was 36.5°C, blood pressure was 120/76 mmHg,and radial pulse rate was 72/min and regular. She had neither anemianorjaundice. A neurological examination revealed no abnormal findings. She was not noted as having adenomasebaceum and she was not mentally retarded. Laboratory findings included a red blood cell count of 403xl04/|il, a white blood cell count of 4,700/^,1, and a platelet count of 35.0xl04/(il. The hemoglobin concentration was 12.5 g/dl. The liver function and renal function tests were both within normal ranges. Total protein was 5.8 g/dl (normal, 6.3-7.8 g/ dl), and serum albumin was 3.2 g/dl (normal, 4.1-5.1 g/dl). Sometumor markers, such as carcinoembryonic antigen, and carbohydrate antigen 19-9, were negative but carbohydrate antigen 125 was 273 U/ml (normal <35 U/ml). The C reactive protein concentration was 0. 1 mg/dl, and the erythrocyte sedimentation rate was 9 mm/h. Serological tests for hepatitis B and C viruses were negative. A chest radiograph on admission showed a right pleural effusion (Fig. 1) . And chest computed tomography (CT) scan demonstrated diffuse multiple cystic lesions surrounded by thin walls in the bilateral lung fields (Fig. 2 ). An examination by Chylothorax Caused by Pulmonary LAM abdominal CT revealed iso-density masses in the retroperitoneum (Fig. 3) . Arterial blood gas analysis revealed LAM.The clinical diagnoses, based on these examinations, were chylothorax due to pulmonary LAMand retroperitoneal LAM.
The patient underwent a thoracoscopy because of the continuation of dyspnea and progress of pleural effusion after admission. During thoracoscopy, the chylorrhea from a swollen vessel on the diaphragm was observed (Fig. 5) . A thoracoscopic lung biopsy was performed and histological examination of the biopsy specimens obtained from the cystic lesions in right S6 revealed a marked smooth-muscle proliferation in the distribution of lymphatics and perivascular areas (Fig. 6 ). The histological diagnosis was compatible with pulmonary LAM.
Onthe basis of this diagnosis we started the administration of leuprorelin acetate at 1.88 mg/week and progesterone at 100 mg/week since May 15 1998, and repeated every week, for four courses until June 17 1998. However, the cystic lesions in the lung fields and chylous effusion remained stable after the hormone therapy. Afterward, pleurodesis was performed on July 16, 1998 and as a result of this treatment the patient's dyspnea was resolved and the pleural effusion was improved. She has been under close periodic observation, and there is no evidence of pleural effusion at the time of 19 months after pleurodesis. described that pneumothorax, frequently recurrent, occured in 7 of his 8 patients with LAM.Based on this consideration, we speculate that the diagnosis of female patients with pneumothorax propounds considerable problems of rupture of the cystic wall related to pulmonary LAM.Proliferation of the smooth muscle element can result in obstruction of bronchioles, producing pockets of air, bullae, and pneumothorax. The obstruction of venules may produce hemoptysis, pulmonary hemorrhage, and hemosiderosis. If chylous effusion is present, the diagnosis is clear since the effusion has been emphasizedas being strongly suggestive of the presence of lymphatic obstruction.
Recently, with the development of various imaging modalities, it has become possible to diagnose pulmonary LAM.Pulmonary LAMhas been described in the radiographic and pathologic literature (1 , 8) . The most commonabnormality on chest roentgenogram is reported to be bilateral reticulonodular infil- trates (6) . Other radiographic features include cysts of bullae, effusion, pneumothorax, and evidence of hyperinflation (5, 6) . Chest CT scans may be useful for providing evidence of bullous formation (9) . Characteristics of CT findings in patients with LAMinclude multiple well-defined cystic air spaces surrounded by uniformly thin walls, distributed diffusely throughout both lungs (5, 10) . The differential diagnosis for LAMincludes emphysema and Langerhans cell granulomatosis. Although a correlation of radiographic findings with clinical information is often suggestive, a pathologic examination of a lung tissue specimen is required for confirmation of the diagnosis of LAM.
Pulmonary LAMgenerally consists of marked smooth-muscle proliferation, regarded as a hamartomatous process, in the distribution of the lymphatics and in the peribronchal and perivascular areas. Transbronchial biposy via fiberoptic bronchoscopy has been used to make the diagnosis (ll, 12) . However, if pulmonary LAMis suspected clinically and the transbronchial biposy is nondiagnostic, open-lung biopsy or thoracoscopic lung biopsy should be performed (6) . In the present case, the diagnosis of LAMwas established by thoracoscopic lung biopsy and thoracoscopy was useful for the observation of chylorrhea. The iso-density masses in the retroperitoneum detected by abdominal CT and the abdominal mass extracted previously might have been LAM. Kitaichi et al (10) reported the clinical and pathologic features of 46 patients with pulmonary LAMfrom Japan (39 patients), Korea (5 patients) and Taiwan (2 patients). They described that the patients were all females, meanage at onset was 32.0+8.9 year (range 20 to 63 year), and major symptoms at the time of onset were dyspnea (57%) and cough (33%). It is not possible to estimate the prevalence of chylothorax. Taylor et al (6) reported 32 cases of pulmonary LAM, 9 of which (28%) revealed chylothorax during the course. According to Kitaichi et al (10) , only 3 of 41 patients (7%) experienced chylothorax. Cases of pulmonary LAMdeveloping chylothorax are rare in Japan.
Pulmonary LAMneeds early treatment because of its progressive nature. Antiestrogen drugs such as progesterone or estrogen-receptor competitive antagonists such as tamoxifen citrate, LH-RHderivatives such as leuprorelin acetate, and combinations of both have been tried as treatment modalities (4, 7, 13). However, a standardized treatment has yet to be established. The exclusively female sex distribution of pulmonary LAMsuggests a possible hormonal involvement in this disease and LAMhas been observed to worsen during pregnancy (14) . In addition, LAMtends to progress with the use of oral contraceptives (15, 16) . Taylor et al (6) did not recommendthe use of tamoxifen since clinical evidence of a beneficial effect was lacking. Eliasson et al (17) reported that a combination therapy of progesterone administration and oophorectomy is the most effective treatment using a meta-analysis method. In the present case, we used progesterone and leuprorelin acetate, what is called "chemical oophorectomy" although the use of LH-RHagonists has produced variable results. However, the cystic lesions in the lung fields and chylous effusion remained stable after the hormone therapy. In our opinion, the hormonal manipulation has been attempted with questionable success although those therapeutic modalities had beneficial effects on chylothorax or chylous ascites in some cases. The treatment for pulmonary LAMto date has not been very effective and further studies including lung transplantation (18, 19) are necessary.
In conclusion, we report a rare case of pulmonary LAMassociated with retroperitoneal LAMand developing chylothorax with clinical symptoms of dyspnea and cough. The patient's chylous effusion and dyspnea was resolved after the pleurodesis. Based on the findings we suggest that diffuse multiple cystic lesions surrounded by thin walls in the lung with chylous effusion should be diagnosed as pulmonary LAM. 2) Kane PB, Lane BP, Cordice JWV, Greenberg GM.infrastructure of the proliferating cells in pulmonary lymphangiomyomatosis. Arch Pathol Lab 4) Rossi GA, Balbi B, Oddera S, Lantero S, Ravazzoni C. Response to treatment with an analog of the luteinizing-hormone-releasing hormonein a patient with pulmonary lymphangioleiomyomatosis. AmRev Respir Dis
